Stay updated on Vorinostat and Azacitidine in MDS/AML Clinical Trial
Sign up to get notified when there's something new on the Vorinostat and Azacitidine in MDS/AML Clinical Trial page.

Latest updates to the Vorinostat and Azacitidine in MDS/AML Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision metadata on the page was updated from v3.6.6 to v3.7.0. This represents a page release or backend/UI update and does not modify study data or visible content.SummaryDifference0.0%

- Check34 days agoChange DetectedVersion label updated to v3.6.6, replacing the previous v3.6.5; this reflects a newer page revision rather than any content change.SummaryDifference0.0%

- Check55 days agoChange DetectedA new version entry is added on 2026-08-07 showing Study Status and Revision: v3.6.5, updating the record history. The earlier entry for v3.6.4 dated 2026-04-13 is removed.SummaryDifference0.1%

- Check70 days agoChange DetectedThe page shows a new revision label Revision: v3.6.4, replacing the previous v3.6.3. This indicates a minor maintenance update and does not alter the study history content.SummaryDifference0.0%

- Check91 days agoChange DetectedThe Record History now displays the latest site revision as v3.6.3, replacing the previous v3.6.2, indicating an update to the page's underlying software.SummaryDifference0.0%

- Check98 days agoChange DetectedRevision: v3.6.2 was added as the latest entry and Revision: v3.6.0 was removed from the record history. This update reflects a change to the page's revision history rather than substantive content changes.SummaryDifference0.0%

Stay in the know with updates to Vorinostat and Azacitidine in MDS/AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vorinostat and Azacitidine in MDS/AML Clinical Trial page.